Cytokinetics, Incorporated · NASDAQ:CYTK

Malik Fady Ibraham sold 3,500 Cytokinetics, Incorporated shares (Form 4)

Traded Jul 21, 2026 · Filed Jul 23, 2026

On Jul 21, 2026, Malik Fady Ibraham (EVP Research & Development) sold 3,500 Cytokinetics, Incorporated shares at US$80.59 for US$282K under a trading plan, leaving 153,902 shares. Filed Jul 23, 2026 (Form 4).

Sold
3,500 shares
Price
US$80.59
Value
US$282K
Holding after
153,902 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP Research & Development

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 21, 2026Common StockOption exercise3,500US$7.80157,402Direct
Jul 21, 2026Common StockSale3,500US$80.59153,902Direct

Source

View original at SEC

Related